
A three-drug combination managed to completely eliminate pancreatic cancer in mice
Published on:
For one of the most lethal tumors of all, a signal arrives that the scientific community has not seen for some time. In animal models, …

Published on:
For one of the most lethal tumors of all, a signal arrives that the scientific community has not seen for some time. In animal models, …

Published on:
For a few hours Europe looked at the sky with a less than reassuring thought: a large body of Chinese rocket was returning without control …

Published on:
Not just weight loss. New generation anti-obesity drugs, the so-called GLP-1 receptor agonists, could also have a direct role on male fertility, stimulating sperm motility …

Published on:
Dossier is the exclusive subscription investigative section of The Vermilion. If you want to read this article directly, click below. If, before subscribing and supporting …

Published on:
Dossier is the exclusive subscription investigative section of The Vermilion. If you want to read this article directly, click below. If, before subscribing and supporting …

Published on:
Two years have passed since Elon Musk announced that Neuralink (a start-up he co-founded) had implanted Telepathy, the first neural microchip conceived and designed to …

Published on:
Anyone who has tried knows it well: for a heavy smoker, giving up cigarettes is one of the most difficult challenges you can face in …

Published on:
We’ve all experienced the goosebumps and shiver down our spines that come when we hear a song that hits all the right chords. In English …

Published on:
It was July 2024 when some parcels sent by air via DHL courier caught fire in logistics centers in England and Germany. A few months …

Published on:
We would all like to find a shortcut to lose weight, or stay fit, without effort and without giving up. Also for this reason, we …

Published on:
Dossier is the exclusive subscription investigative section of The Vermilion. If you want to read this article directly, click below. If, before subscribing and supporting …